NL-OMON36419
Completed
Not Applicable
Dyslexia, Motor Control, and the Cerebellum - Dyslexia Motor Control Cerebellum
niversitair Medisch Centrum Utrecht0 sites30 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Developmental dyslexia
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For subjects with DD:
- •Official diagnosis of developmental dyslexia
- •For all participants:
- •Right handedness;
- •Dutch as native language;
- •Modified Rankin scale score 0;
- •Normal or corrected to normal vision.
Exclusion Criteria
- •Non\-MRI compatible prostheses, claustrophobia or pregnancy;
- •Neurological or psychiatric conditions other than being investigated (specifically cerebrovascular accidents and ADHD);
- •Inability to visit the Utrecht University Medical Center or the UiL\-OTS lab;
- •Cluttering or stuttering.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Dyslexia, Motor Control and ProprioceptionDyslexiaNCT03364010Institut National de la Santé Et de la Recherche Médicale, France56
Completed
Not Applicable
Cerebellum and Cortical Plasticity: the Case of DystoniaDystoniaNCT01272154Institut National de la Santé Et de la Recherche Médicale, France120
Recruiting
Not Applicable
Motor learning in children with DCDmotorische ontwikkelingclumsinessDevelopmental Coordination DisorderNL-OMON54882Radboud Universiteit Nijmegen40
Completed
Phase 2
The effect of motor cortex and cerebellum regions trans-cranial direct current stimulation on implicit motor learning in healthy individuals; a comparative studyHealthy individual.IRCT2015030221294N1Vice chancellor for research, Semnan University of Medical Sciences30
Not yet recruiting
Not Applicable
Cognitive and motor development, nerve function, somatic growth and (pubertal) development, and (spontaneous) thyroid function in 10,5 years old Down syndrome children after thyroxine or placebo treatment until the age of 2 years.Down syndrome en Down's syndrome1008362410043739NL-OMON33051Academisch Medisch Centrum181